Cellectar Biosciences to Present at the Rodman & Renshaw 17th Annual Global Investment Conference Sep 3, 2015
Cellectar Biosciences Introduces Phospholipid Ether-Drug Conjugate (PDC) Platform for Targeted Delivery of Chemotherapeutics Aug 21, 2015
Cellectar Biosciences to Host Conference Call on August 12th to Discuss Second Quarter Financial Results and Provide Update on Development Plans Aug 7, 2015
Cellectar Biosciences Announces CLR1502 Development Program to be Classified as Combination Product by U.S. Food and Drug Administration Jun 11, 2015
Cellectar Biosciences Reports First Quarter 2015 Financial Results and Provides Update on Clinical Programs May 21, 2015